Danaher Co. (NYSE:DHR) Shares Purchased by Parisi Gray Wealth Management

Parisi Gray Wealth Management lifted its stake in Danaher Co. (NYSE:DHR) by 4.0% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 14,151 shares of the conglomerate’s stock after purchasing an additional 541 shares during the period. Danaher makes up 1.3% of Parisi Gray Wealth Management’s investment portfolio, making the stock its 18th largest holding. Parisi Gray Wealth Management’s holdings in Danaher were worth $3,274,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds and other institutional investors have also recently made changes to their positions in the stock. Fairfield Bush & CO. raised its position in shares of Danaher by 10.9% in the first quarter. Fairfield Bush & CO. now owns 4,840 shares of the conglomerate’s stock valued at $1,420,000 after buying an additional 475 shares during the last quarter. Zions Bancorporation N.A. raised its position in shares of Danaher by 19.3% in the first quarter. Zions Bancorporation N.A. now owns 2,468 shares of the conglomerate’s stock valued at $724,000 after buying an additional 400 shares during the last quarter. Covestor Ltd raised its position in shares of Danaher by 76.8% in the first quarter. Covestor Ltd now owns 495 shares of the conglomerate’s stock valued at $145,000 after buying an additional 215 shares during the last quarter. NewEdge Advisors LLC grew its holdings in Danaher by 14.1% in the first quarter. NewEdge Advisors LLC now owns 31,530 shares of the conglomerate’s stock valued at $9,248,000 after purchasing an additional 3,897 shares during the period. Finally, Bridgewater Associates LP grew its holdings in Danaher by 135.9% in the first quarter. Bridgewater Associates LP now owns 35,270 shares of the conglomerate’s stock valued at $10,346,000 after purchasing an additional 20,320 shares during the period. Institutional investors and hedge funds own 79.05% of the company’s stock.

Danaher Price Performance

Shares of NYSE:DHR traded up $0.27 during midday trading on Thursday, reaching $249.04. 113,513 shares of the company’s stock were exchanged, compared to its average volume of 2,725,729. The company’s 50 day simple moving average is $246.68 and its two-hundred day simple moving average is $230.40. The firm has a market capitalization of $184.21 billion, a PE ratio of 38.94, a price-to-earnings-growth ratio of 3.77 and a beta of 0.84. Danaher Co. has a 12 month low of $182.09 and a 12 month high of $259.00. The company has a debt-to-equity ratio of 0.31, a quick ratio of 1.37 and a current ratio of 1.68.

Danaher (NYSE:DHR) last announced its quarterly earnings results on Tuesday, January 30th. The conglomerate reported $2.09 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.91 by $0.18. Danaher had a net margin of 17.26% and a return on equity of 12.25%. The firm had revenue of $6.41 billion during the quarter, compared to the consensus estimate of $6.10 billion. During the same period last year, the firm posted $2.87 EPS. The firm’s quarterly revenue was down 10.2% on a year-over-year basis. Equities research analysts expect that Danaher Co. will post 7.63 earnings per share for the current fiscal year.

Danaher Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, April 26th. Investors of record on Thursday, March 28th will be issued a dividend of $0.27 per share. This is an increase from Danaher’s previous quarterly dividend of $0.24. This represents a $1.08 annualized dividend and a yield of 0.43%. The ex-dividend date is Wednesday, March 27th. Danaher’s dividend payout ratio (DPR) is currently 15.02%.

Analysts Set New Price Targets

A number of research firms recently issued reports on DHR. HSBC began coverage on shares of Danaher in a report on Monday, December 18th. They issued a “hold” rating for the company. JPMorgan Chase & Co. upped their price target on shares of Danaher from $250.00 to $270.00 and gave the stock an “overweight” rating in a research report on Wednesday, December 20th. Royal Bank of Canada increased their target price on shares of Danaher from $254.00 to $282.00 and gave the company an “outperform” rating in a research report on Wednesday, January 31st. The Goldman Sachs Group lowered shares of Danaher from a “buy” rating to a “neutral” rating and reduced their price objective for the company from $215.00 to $205.00 in a research note on Thursday, December 7th. Finally, StockNews.com downgraded shares of Danaher from a “buy” rating to a “hold” rating in a research report on Wednesday, January 31st. Seven equities research analysts have rated the stock with a hold rating and nine have issued a buy rating to the company’s stock. According to data from MarketBeat.com, Danaher presently has a consensus rating of “Moderate Buy” and an average target price of $266.00.

Insider Buying and Selling at Danaher

In other Danaher news, SVP Daniel Raskas sold 23,757 shares of the firm’s stock in a transaction dated Monday, February 26th. The shares were sold at an average price of $252.00, for a total value of $5,986,764.00. Following the completion of the sale, the senior vice president now owns 38,102 shares in the company, valued at approximately $9,601,704. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. In related news, SVP Daniel Raskas sold 23,757 shares of the business’s stock in a transaction that occurred on Monday, February 26th. The shares were sold at an average price of $252.00, for a total transaction of $5,986,764.00. Following the completion of the transaction, the senior vice president now owns 38,102 shares in the company, valued at $9,601,704. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, Director Teri List sold 3,289 shares of Danaher stock in a transaction that occurred on Tuesday, February 6th. The shares were sold at an average price of $248.32, for a total transaction of $816,724.48. Following the completion of the transaction, the director now directly owns 19,726 shares in the company, valued at approximately $4,898,360.32. The disclosure for this sale can be found here. In the last 90 days, insiders sold 32,957 shares of company stock worth $8,265,802. 11.10% of the stock is currently owned by corporate insiders.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.